![](/img/cover-not-exists.png)
Efficacy and safety of canagliflozin versus glimepiride in patients with type 2 diabetes inadequately controlled with metformin (CANTATA-SU): 52 week results from a randomised, double-blind, phase 3 non-inferiority trial
Cefalu, William T, Leiter, Lawrence A, Yoon, Kun-Ho, Arias, Pablo, Niskanen, Leo, Xie, John, Balis, Dainius A, Canovatchel, William, Meininger, GaryVolume:
382
Language:
english
Journal:
The Lancet
DOI:
10.1016/S0140-6736(13)60683-2
Date:
September, 2013
File:
PDF, 489 KB
english, 2013